Safety, Tolerability, and Pharmacokinetics of Single Doses of HC022 in Healthy Subjects.

Clinical trial NCT06657703 · RECRUITING

Trial details

NCT number: NCT06657703
Sponsor: HC Biopharma Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2024-11-25
Primary completion: 2025-08-30
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.